The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. [electronic resource]
Producer: 20060816Description: 5027-35 p. digitalISSN:- 0264-410X
- Adjuvants, Immunologic -- pharmacology
- Animals
- Cytokines -- antagonists & inhibitors
- Gene Expression Regulation
- Lipid A -- analogs & derivatives
- Lung -- metabolism
- Respiratory Syncytial Virus Vaccines -- adverse effects
- Respiratory Syncytial Viruses -- immunology
- Sigmodontinae -- immunology
- Toll-Like Receptor 4 -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.